Sponsored by IntelliSyn RD
The IntelliSyn Pharma Research Excellence Award (formerly the Boehringer Ingelheim Research Excellence Award) is presented to a scientist residing in Canada who has made a distinguished contribution to medicinally relevant organic or biophysical chemistry while working in Canada. Eligible candidates must have held their first professional appointment as an independent researcher for twelve years* or less at the time of initial nomination.
The 2021 winner of the IntelliSyn Pharma Research Excellence Award is:
Mark Taylor, MCIC
University of Toronto
Mark S. Taylor was born in Oxford, England and grew up in Toronto. He received his B.Sc. in 2000 from the University of Toronto, where he conducted research in the laboratory of Prof. Mark Lautens. Mark then pursued graduate studies at Harvard University from 2000–2005 under the supervision of Prof. Eric Jacobsen. After carrying out postdoctoral research at the Massachusetts Institute of Technology with Prof. Tim Swager, he returned to the Department of Chemistry at the University of Toronto in 2007. He currently holds the position of Professor and Canada Research Chair in Molecular Recognition and Catalysis, with research interests spanning the areas of organic synthesis, catalysis, molecular recognition, and polymer chemistry. Prof. Taylor has received several awards for excellence in research, including the John Charles Polanyi Prize, Boehringer Ingelheim (Canada) Young Investigator Award, A. P. Sloan Research Fellowship, Japan Society for the Promotion of Science Visiting Fellowship, McLean Award, CSC Keith Fagnou Award and ACS Horace S. Isbell Award. He has authored more than 80 peer-reviewed journal articles that have been cited >6,500 times in total, and has given more than 90 invited lectures in North America, Europe and Asia.